Copyright Reports & Markets. All rights reserved.

Global Gel Ointment Market Research Report 2021

Request for Sample of this report
Buy now

1 Gel Ointment Market Overview

  • 1.1 Product Overview and Scope of Gel Ointment
  • 1.2 Gel Ointment Segment by Type
    • 1.2.1 Global Gel Ointment Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Non-steroidal Anti-inflammatory Drugs
    • 1.2.3 Chinese Patent Medicine
  • 1.3 Gel Ointment Segment by Application
    • 1.3.1 Global Gel Ointment Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Surgical Clinic
    • 1.3.4 Emergency Center
    • 1.3.5 Other
  • 1.4 Global Gel Ointment Market Size Estimates and Forecasts
    • 1.4.1 Global Gel Ointment Revenue 2016-2027
    • 1.4.2 Global Gel Ointment Sales 2016-2027
    • 1.4.3 Gel Ointment Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gel Ointment Market Competition by Manufacturers

  • 2.1 Global Gel Ointment Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Gel Ointment Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Gel Ointment Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Gel Ointment Manufacturing Sites, Area Served, Product Type
  • 2.5 Gel Ointment Market Competitive Situation and Trends
    • 2.5.1 Gel Ointment Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Gel Ointment Players Market Share by Revenue
    • 2.5.3 Global Gel Ointment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gel Ointment Retrospective Market Scenario by Region

  • 3.1 Global Gel Ointment Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Gel Ointment Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Gel Ointment Market Facts & Figures by Country
    • 3.3.1 North America Gel Ointment Sales by Country
    • 3.3.2 North America Gel Ointment Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Gel Ointment Market Facts & Figures by Country
    • 3.4.1 Europe Gel Ointment Sales by Country
    • 3.4.2 Europe Gel Ointment Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gel Ointment Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gel Ointment Sales by Region
    • 3.5.2 Asia Pacific Gel Ointment Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Gel Ointment Market Facts & Figures by Country
    • 3.6.1 Latin America Gel Ointment Sales by Country
    • 3.6.2 Latin America Gel Ointment Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Gel Ointment Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gel Ointment Sales by Country
    • 3.7.2 Middle East and Africa Gel Ointment Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Gel Ointment Historic Market Analysis by Type

  • 4.1 Global Gel Ointment Sales Market Share by Type (2016-2021)
  • 4.2 Global Gel Ointment Revenue Market Share by Type (2016-2021)
  • 4.3 Global Gel Ointment Price by Type (2016-2021)

5 Global Gel Ointment Historic Market Analysis by Application

  • 5.1 Global Gel Ointment Sales Market Share by Application (2016-2021)
  • 5.2 Global Gel Ointment Revenue Market Share by Application (2016-2021)
  • 5.3 Global Gel Ointment Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Teva
    • 6.1.1 Teva Corporation Information
    • 6.1.2 Teva Description and Business Overview
    • 6.1.3 Teva Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Teva Gel Ointment Product Portfolio
    • 6.1.5 Teva Recent Developments/Updates
  • 6.2 Mylan Pharmaceuticals
    • 6.2.1 Mylan Pharmaceuticals Corporation Information
    • 6.2.2 Mylan Pharmaceuticals Description and Business Overview
    • 6.2.3 Mylan Pharmaceuticals Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Mylan Pharmaceuticals Gel Ointment Product Portfolio
    • 6.2.5 Mylan Pharmaceuticals Recent Developments/Updates
  • 6.3 Tokuhon
    • 6.3.1 Tokuhon Corporation Information
    • 6.3.2 Tokuhon Description and Business Overview
    • 6.3.3 Tokuhon Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Tokuhon Gel Ointment Product Portfolio
    • 6.3.5 Tokuhon Recent Developments/Updates
  • 6.4 Recordati
    • 6.4.1 Recordati Corporation Information
    • 6.4.2 Recordati Description and Business Overview
    • 6.4.3 Recordati Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Recordati Gel Ointment Product Portfolio
    • 6.4.5 Recordati Recent Developments/Updates
  • 6.5 Mikasa Seiyaku
    • 6.5.1 Mikasa Seiyaku Corporation Information
    • 6.5.2 Mikasa Seiyaku Description and Business Overview
    • 6.5.3 Mikasa Seiyaku Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Mikasa Seiyaku Gel Ointment Product Portfolio
    • 6.5.5 Mikasa Seiyaku Recent Developments/Updates
  • 6.6 Bausch Health
    • 6.6.1 Bausch Health Corporation Information
    • 6.6.2 Bausch Health Description and Business Overview
    • 6.6.3 Bausch Health Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Bausch Health Gel Ointment Product Portfolio
    • 6.6.5 Bausch Health Recent Developments/Updates
  • 6.7 Pfizer
    • 6.6.1 Pfizer Corporation Information
    • 6.6.2 Pfizer Description and Business Overview
    • 6.6.3 Pfizer Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Pfizer Gel Ointment Product Portfolio
    • 6.7.5 Pfizer Recent Developments/Updates
  • 6.8 AbbVie
    • 6.8.1 AbbVie Corporation Information
    • 6.8.2 AbbVie Description and Business Overview
    • 6.8.3 AbbVie Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 AbbVie Gel Ointment Product Portfolio
    • 6.8.5 AbbVie Recent Developments/Updates
  • 6.9 Abbott
    • 6.9.1 Abbott Corporation Information
    • 6.9.2 Abbott Description and Business Overview
    • 6.9.3 Abbott Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Abbott Gel Ointment Product Portfolio
    • 6.9.5 Abbott Recent Developments/Updates
  • 6.10 Allergan
    • 6.10.1 Allergan Corporation Information
    • 6.10.2 Allergan Description and Business Overview
    • 6.10.3 Allergan Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Allergan Gel Ointment Product Portfolio
    • 6.10.5 Allergan Recent Developments/Updates
  • 6.11 Pharma-Logic
    • 6.11.1 Pharma-Logic Corporation Information
    • 6.11.2 Pharma-Logic Gel Ointment Description and Business Overview
    • 6.11.3 Pharma-Logic Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Pharma-Logic Gel Ointment Product Portfolio
    • 6.11.5 Pharma-Logic Recent Developments/Updates
  • 6.12 Kaken Pharma
    • 6.12.1 Kaken Pharma Corporation Information
    • 6.12.2 Kaken Pharma Gel Ointment Description and Business Overview
    • 6.12.3 Kaken Pharma Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Kaken Pharma Gel Ointment Product Portfolio
    • 6.12.5 Kaken Pharma Recent Developments/Updates
  • 6.13 Sun Pharma
    • 6.13.1 Sun Pharma Corporation Information
    • 6.13.2 Sun Pharma Gel Ointment Description and Business Overview
    • 6.13.3 Sun Pharma Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Sun Pharma Gel Ointment Product Portfolio
    • 6.13.5 Sun Pharma Recent Developments/Updates
  • 6.14 Aa Pharma
    • 6.14.1 Aa Pharma Corporation Information
    • 6.14.2 Aa Pharma Gel Ointment Description and Business Overview
    • 6.14.3 Aa Pharma Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Aa Pharma Gel Ointment Product Portfolio
    • 6.14.5 Aa Pharma Recent Developments/Updates
  • 6.15 Pro Doc Limitee
    • 6.15.1 Pro Doc Limitee Corporation Information
    • 6.15.2 Pro Doc Limitee Gel Ointment Description and Business Overview
    • 6.15.3 Pro Doc Limitee Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Pro Doc Limitee Gel Ointment Product Portfolio
    • 6.15.5 Pro Doc Limitee Recent Developments/Updates
  • 6.16 PD-Rx Pharmaceuticals
    • 6.16.1 PD-Rx Pharmaceuticals Corporation Information
    • 6.16.2 PD-Rx Pharmaceuticals Gel Ointment Description and Business Overview
    • 6.16.3 PD-Rx Pharmaceuticals Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 PD-Rx Pharmaceuticals Gel Ointment Product Portfolio
    • 6.16.5 PD-Rx Pharmaceuticals Recent Developments/Updates
  • 6.17 Beijing Tide Pharmaceutical Co., Ltd.
    • 6.17.1 Beijing Tide Pharmaceutical Co., Ltd. Corporation Information
    • 6.17.2 Beijing Tide Pharmaceutical Co., Ltd. Gel Ointment Description and Business Overview
    • 6.17.3 Beijing Tide Pharmaceutical Co., Ltd. Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Beijing Tide Pharmaceutical Co., Ltd. Gel Ointment Product Portfolio
    • 6.17.5 Beijing Tide Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.18 Wuhan Daan Pharmaceutical Co., Ltd.
    • 6.18.1 Wuhan Daan Pharmaceutical Co., Ltd. Corporation Information
    • 6.18.2 Wuhan Daan Pharmaceutical Co., Ltd. Gel Ointment Description and Business Overview
    • 6.18.3 Wuhan Daan Pharmaceutical Co., Ltd. Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Wuhan Daan Pharmaceutical Co., Ltd. Gel Ointment Product Portfolio
    • 6.18.5 Wuhan Daan Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 6.19 Johnson & Johnson
    • 6.19.1 Johnson & Johnson Corporation Information
    • 6.19.2 Johnson & Johnson Gel Ointment Description and Business Overview
    • 6.19.3 Johnson & Johnson Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Johnson & Johnson Gel Ointment Product Portfolio
    • 6.19.5 Johnson & Johnson Recent Developments/Updates
  • 6.20 Novacap
    • 6.20.1 Novacap Corporation Information
    • 6.20.2 Novacap Gel Ointment Description and Business Overview
    • 6.20.3 Novacap Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Novacap Gel Ointment Product Portfolio
    • 6.20.5 Novacap Recent Developments/Updates
  • 6.21 GSK
    • 6.21.1 GSK Corporation Information
    • 6.21.2 GSK Gel Ointment Description and Business Overview
    • 6.21.3 GSK Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 GSK Gel Ointment Product Portfolio
    • 6.21.5 GSK Recent Developments/Updates
  • 6.22 Reddy Pharmaceuticals
    • 6.22.1 Reddy Pharmaceuticals Corporation Information
    • 6.22.2 Reddy Pharmaceuticals Gel Ointment Description and Business Overview
    • 6.22.3 Reddy Pharmaceuticals Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Reddy Pharmaceuticals Gel Ointment Product Portfolio
    • 6.22.5 Reddy Pharmaceuticals Recent Developments/Updates
  • 6.23 Geri-Care Pharmaceuticals
    • 6.23.1 Geri-Care Pharmaceuticals Corporation Information
    • 6.23.2 Geri-Care Pharmaceuticals Gel Ointment Description and Business Overview
    • 6.23.3 Geri-Care Pharmaceuticals Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Geri-Care Pharmaceuticals Gel Ointment Product Portfolio
    • 6.23.5 Geri-Care Pharmaceuticals Recent Developments/Updates
  • 6.24 Perrigo Company
    • 6.24.1 Perrigo Company Corporation Information
    • 6.24.2 Perrigo Company Gel Ointment Description and Business Overview
    • 6.24.3 Perrigo Company Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Perrigo Company Gel Ointment Product Portfolio
    • 6.24.5 Perrigo Company Recent Developments/Updates
  • 6.25 Kopran
    • 6.25.1 Kopran Corporation Information
    • 6.25.2 Kopran Gel Ointment Description and Business Overview
    • 6.25.3 Kopran Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 Kopran Gel Ointment Product Portfolio
    • 6.25.5 Kopran Recent Developments/Updates
  • 6.26 Merck Sharp & Dohme
    • 6.26.1 Merck Sharp & Dohme Corporation Information
    • 6.26.2 Merck Sharp & Dohme Gel Ointment Description and Business Overview
    • 6.26.3 Merck Sharp & Dohme Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.26.4 Merck Sharp & Dohme Gel Ointment Product Portfolio
    • 6.26.5 Merck Sharp & Dohme Recent Developments/Updates
  • 6.27 Ted Pharmaceuticals
    • 6.27.1 Ted Pharmaceuticals Corporation Information
    • 6.27.2 Ted Pharmaceuticals Gel Ointment Description and Business Overview
    • 6.27.3 Ted Pharmaceuticals Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.27.4 Ted Pharmaceuticals Gel Ointment Product Portfolio
    • 6.27.5 Ted Pharmaceuticals Recent Developments/Updates
  • 6.28 Jiudian Pharmaceutical
    • 6.28.1 Jiudian Pharmaceutical Corporation Information
    • 6.28.2 Jiudian Pharmaceutical Gel Ointment Description and Business Overview
    • 6.28.3 Jiudian Pharmaceutical Gel Ointment Sales, Revenue and Gross Margin (2016-2021)
    • 6.28.4 Jiudian Pharmaceutical Gel Ointment Product Portfolio
    • 6.28.5 Jiudian Pharmaceutical Recent Developments/Updates

7 Gel Ointment Manufacturing Cost Analysis

  • 7.1 Gel Ointment Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gel Ointment
  • 7.4 Gel Ointment Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gel Ointment Distributors List
  • 8.3 Gel Ointment Customers

9 Gel Ointment Market Dynamics

  • 9.1 Gel Ointment Industry Trends
  • 9.2 Gel Ointment Growth Drivers
  • 9.3 Gel Ointment Market Challenges
  • 9.4 Gel Ointment Market Restraints

10 Global Market Forecast

  • 10.1 Gel Ointment Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gel Ointment by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Gel Ointment by Type (2022-2027)
  • 10.2 Gel Ointment Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gel Ointment by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Gel Ointment by Application (2022-2027)
  • 10.3 Gel Ointment Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gel Ointment by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Gel Ointment by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Non-steroidal Anti-inflammatory Drugs
    Chinese Patent Medicine

    Segment by Application
    Hospital
    Surgical Clinic
    Emergency Center
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Teva
    Mylan Pharmaceuticals
    Tokuhon
    Recordati
    Mikasa Seiyaku
    Bausch Health
    Pfizer
    AbbVie
    Abbott
    Allergan
    Pharma-Logic
    Kaken Pharma
    Sun Pharma
    Aa Pharma
    Pro Doc Limitee
    PD-Rx Pharmaceuticals
    Beijing Tide Pharmaceutical Co., Ltd.
    Wuhan Daan Pharmaceutical Co., Ltd.
    Johnson & Johnson
    Novacap
    GSK
    Reddy Pharmaceuticals
    Geri-Care Pharmaceuticals
    Perrigo Company
    Kopran
    Merck Sharp & Dohme
    Ted Pharmaceuticals
    Jiudian Pharmaceutical

    Buy now